Ranking results:

Past rankings:

2019
Criterium:	Position:
Overall Score:	> 1000
Total Number of Projects:	> 1000
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000
2012
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
2011
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Total Project Funding:	> 1000
Partner Constancy:	> 1000
Project Leadership Index:	> 1000
Diversity Index:	> 1000
2008
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2007
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Total Project Funding:	> 1000
Partner Constancy:	> 1000
Project Leadership Index:	> 1000
Diversity Index:	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 1
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0.25^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	0	7.057.980	0		1
2019	0	10.999.316	0		1
2018	0	3.942.861	0		1
2015	0	18.200.000	0		1
2012	1.992.214	0	570.009	1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
ASTRAZENECA	2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	2
LEIDS UNIVERSITAIR MEDISCH CENTRUM	2
MEDIZINISCHE HOCHSCHULE HANNOVER	2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	2
UNIVERSITAET BASEL	2
UNIVERSITAETSKLINIKUM JENA	2
UNIVERSITE DU LUXEMBOURG	2
UNIVERSITEIT TWENTE	2
ACADEMISCH ZIEKENHUIS LEIDEN	1
AERAS GLOBAL TB VACCINE FOUNDATION	1
ASTON UNIVERSITY	1
AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO	1
Bangor University	1
BAYER	1
BIOSCI CONSULTING BVBA	1
BLUEBIRD BIO INC	1
BUNDESINSTITUT FUER RISIKOBEWERTUNG	1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE	1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL	1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY	1
COVANCE LABORATORIES	1
DEPARTMENT OF HEALTH	1
DYNAMIC42	1
EBERHARD KARLS UNIVERSITAET TUEBINGEN	1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	1
EDUCATIONAL FOUNDATION YONSEI UNIVERSITY	1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	1
F HOFFMANNLA ROCHE	1
FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA	1
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE	1
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT	1
FUDAN UNIVERSITY SHANGHAI CANCER CENTER	1
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL	1
FUNDACIO INSTITUT DE RECERCA BIOMEDICA	1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	1
GENOME RESEARCH	1
GLAXOSMITHKLINE BIOLOGICALS	1
HOSPICES CANTONAUX CHUV	1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE	1
INSTITUT DE RECHERCHES SERVIER	1
INSTITUT PASTEUR	1
INSTITUT PASTEUR DE LILLE	1
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE	1
INTERNATIONAL TUBERCULOSIS RESEARCH CENTER	1
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS	1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI	1
ISTITUTO SUPERIORE DI SANITA	1
JDRF INTERNATIONAL	1
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW	1
KWAZULU NATAL RESEARCH INSTITUTE FOR TBHIV NPC	1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE	1
LUND UNIVERSITY	1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	1
MEDICAL RESEARCH COUNCIL	1
MEDIZINISCHE UNIVERSITAT INNSBRUCK	1
MERCK SHARP & DOHME CORP	1
MILTENYI BIOTEC	1
NOVARTIS PHARMA	1
PAUL EHRLICH INSTITUT	1
PYRO SCIENCE	1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU	1
SANOFIAVENTIS	1
SINGLE CELL DISCOVERIES BV	1
STATENS SERUM INSTITUT	1
STELLENBOSCH UNIVERSITY	1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	1
STICHTING HUBRECHT ORGANOID TECHNOLOGY	1
STICHTING INSTITUTE FOR HUMAN ORGAN AND DISEASE MODEL TECHNOLOGIES	1
STICHTING LYGATURE	1
STICHTING ONCODE INSTITUTE	1
STICHTING TUBERCULOSIS VACCINE INITIATIVE	1
TCURX	1
TECHNISCHE UNIVERSITAET GRAZ	1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	1
THE SECRETARY OF STATE FOR ENVIRONMENT FOOD AND RURAL AFFAIRS	1
THE UNIVERSITY OF SYDNEY	1
THE UNIVERSITY OF TUEBINGEN	1
UNIVERSIDAD DE ZARAGOZA	1
UNIVERSITAET BERN	1
UNIVERSITAET LEIPZIG	1
UNIVERSITAET ULM	1
UNIVERSITAET ZUERICH	1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	1
UNIVERSITE DE GENEVE	1
UNIVERSITE DE LAUSANNE	1
UNIVERSITE LIBRE DE BRUXELLES	1
UNIVERSITEIT GENT	1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN	1
UNIVERSITY OF CAPE TOWN	1
UNIVERSITY OF COPENHAGEN	1
UNIVERSITY OF OSLO	1
UNIVERSITY OF STRATHCLYDE	1
UPMKYMMENE OYJ	1
UPPSALA UNIVERSITET	1
XENOPAT SL	1

Constancy:

Total number of partners: 109
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 109
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2021-07-01	Building a reproducible single-cell experimental workflow to capture tumour drug persistence	PERSIST-SEQ	participant	7.057.980	16
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2018-12-01	Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe	EUROoC	participant	3.942.861	21
2015-01-01	TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development	TBVAC2020	participant	18.200.000	44
2012-01-01	Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China	IMMUNOCAN	coordinator	1.992.214	5

Alias institution names:

TRANSGENE

TRANSGENE SA - France